Company profilePharmaceutical#1026 of 1,318 in Pakistan✓ No DRAP alerts

Hinucon

Pharmaceutical company · 3 brands · 2 molecules

Ranked #53 of 100 companies in Gastro

3 registered products 2 pharmaceutical brands 2 distinct molecules 0 DRAP alerts

Company overview

3
registered products
2
pharmaceutical brands
2
distinct molecules
2
therapeutic classes
0
DRAP alerts

Hinucon is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 3 product registrations across 2 distinct molecules. Its portfolio is concentrated in Gastro and Anti-Infectives. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Hinucon

2 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Anti-Infectives 1

Top molecules by brand count

Therapeutic classes

Gastro · 2Anti-Infectives · 1

Conditions treated

Probiotic · 1URINARY TRACT INFECTION · 1Colic/Constipation · 1

Price band (DRAP official ceilings)

Registered products priced by source
DVAGO1 products · Rs 236 – Rs 236
Servaid3 products · Rs 160 – Rs 770
Median across source: Rs 415

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

PharmEvo Private Limited1 shared molecules
C.C.L (Pvt) Ltd .1 shared molecules
HILTON PHARMA (PVT) LIMITED1 shared molecules
Medicom Superior, Lahore1 shared molecules
MATRIX PHARMA1 shared molecules
Emmess Nutraceuticals1 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

PharmEvo Private Limited holds 119 molecules not in this portfolio
AgomelatineAlcoholAmlodipineAnastrazoleApixabanAprepitant
C.C.L (Pvt) Ltd . holds 12 molecules not in this portfolio
Ammonium ChlorideCalciumChlorpheniramine Containing ExpectorantsEscitalopramGlucoseInf
Abbot Laboratories (Pak) Ltd holds 14 molecules not in this portfolio
AcetylcysteineAcyclovir InfCetirizineChlorpheniramineDiloxanideDydrogesterone

Get the full profile for Hinucon

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.